ATE234622T1 - Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen - Google Patents

Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen

Info

Publication number
ATE234622T1
ATE234622T1 AT96943630T AT96943630T ATE234622T1 AT E234622 T1 ATE234622 T1 AT E234622T1 AT 96943630 T AT96943630 T AT 96943630T AT 96943630 T AT96943630 T AT 96943630T AT E234622 T1 ATE234622 T1 AT E234622T1
Authority
AT
Austria
Prior art keywords
immunogenic
blood cells
red blood
plates
containing non
Prior art date
Application number
AT96943630T
Other languages
English (en)
Inventor
Sherrill J Slichter
Original Assignee
Puget Sound Blood Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Puget Sound Blood Ct filed Critical Puget Sound Blood Ct
Application granted granted Critical
Publication of ATE234622T1 publication Critical patent/ATE234622T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT96943630T 1995-12-04 1996-12-04 Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen ATE234622T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56684795A 1995-12-04 1995-12-04
PCT/US1996/019467 WO1997020570A1 (en) 1995-12-04 1996-12-04 Non-immunogenic and toleragenic platelet and red blood cell compositions

Publications (1)

Publication Number Publication Date
ATE234622T1 true ATE234622T1 (de) 2003-04-15

Family

ID=24264638

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96943630T ATE234622T1 (de) 1995-12-04 1996-12-04 Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen

Country Status (7)

Country Link
EP (1) EP0874635B1 (de)
JP (1) JP2000503631A (de)
AT (1) ATE234622T1 (de)
AU (1) AU725669B2 (de)
CA (1) CA2239574A1 (de)
DE (1) DE69626853T2 (de)
WO (1) WO1997020570A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1902740A1 (de) * 2006-09-19 2008-03-26 Maco Pharma S.A. Blutbeutelsystem und Verfahren, um Pathogene in Blutplättchenkonzentraten mit Hilfe des Blutbeutelsystems zu neutralisieren
RU2656156C2 (ru) 2011-10-17 2018-05-31 Массачусетс Инститьют Оф Текнолоджи Внутриклеточная доставка
KR102304167B1 (ko) 2013-08-16 2021-09-24 메사추세츠 인스티튜트 오브 테크놀로지 세포로의 선택적 물질 전달
RU2739794C2 (ru) 2014-10-31 2020-12-28 Массачусетс Инститьют Оф Текнолоджи Доставка биомолекул в клетки иммунной системы
US10526573B2 (en) 2014-11-14 2020-01-07 Massachusetts Institute Of Technology Disruption and field enabled delivery of compounds and compositions into cells
CN107249603A (zh) * 2014-12-31 2017-10-13 人类起源公司 分离血小板的方法
US11125739B2 (en) 2015-01-12 2021-09-21 Massachusetts Institute Of Technology Gene editing through microfluidic delivery
JP6925984B2 (ja) 2015-07-09 2021-08-25 マサチューセッツ インスティテュート オブ テクノロジー 無核細胞への物質の送達
US11613759B2 (en) 2015-09-04 2023-03-28 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5714524A (en) * 1980-07-02 1982-01-25 Asahi Chem Ind Co Ltd Preparation of dispersion of platelet
JPS5762222A (en) * 1980-10-03 1982-04-15 Asahi Chem Ind Co Ltd Preparation of concentrated solution of platelet, its device and part
DE3650139T2 (de) * 1985-07-05 1995-03-09 Hutchinson Fred Cancer Res Verfahren zum reduzieren der immunogenizität und zum induzieren immunologischer toleranz.
AU578554B2 (en) * 1986-01-24 1988-10-27 Japanese Red Cross Society Centrifugal method of separating blood components
ATE193454T1 (de) * 1989-09-12 2000-06-15 Pall Corp Verfahren und vorrichtung zur behandlung von menschlichem blut für die transfusion
DE4129516C2 (de) * 1991-09-06 2000-03-09 Fresenius Ag Verfahren und Vorrichtung zum Trennen von Blut in seine Bestandteile

Also Published As

Publication number Publication date
EP0874635A1 (de) 1998-11-04
WO1997020570A1 (en) 1997-06-12
AU1282597A (en) 1997-06-27
DE69626853T2 (de) 2004-02-19
DE69626853D1 (de) 2003-04-24
AU725669B2 (en) 2000-10-19
JP2000503631A (ja) 2000-03-28
EP0874635B1 (de) 2003-03-19
CA2239574A1 (en) 1997-06-12

Similar Documents

Publication Publication Date Title
TR199802421T2 (xx) Doku yenilenmesini d�zenleyen maddeler.
TR200101867T2 (tr) CCR5 modülatörleri olarak piperidinler
IS1904B (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
DE69729786D1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
ATE429210T1 (de) Orale flüssige zusammensetzungen
ATE216590T1 (de) Arzneimittelformulierungen für il-12
ATE106740T1 (de) Herstellung von t-zellen und t-zellmembranen, verwendbar zur verhütung und behandlung von autoimmunkrankheiten.
NO960743L (no) Cellulære preparater, deres fremstilling og terapeutiske anvendelse
TR200101549T2 (tr) p53-Familyasından bir proteinin yapısal kararlılığının canlandırılmasına yönelik metotlar.
ES2147720T3 (es) Factor de celulas madre.
ATE214610T1 (de) Neuartige pharmazeutische verwendungen von krill- enzymen
ATE299854T1 (de) Chinonverbindungen zur behandlung von krankheiten
ATE234622T1 (de) Nicht-immunogene blutplättchen und rote blutzellen enthaltende zubereitungen
FI953193A7 (fi) Uudet (tia) sykloalkyyli (b) indoliyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
NL194612B (nl) Aromatische, alkenisch onverzadigde retino´den, alsmede dergelijke verbindingen bevattende farmaceutische en cosmetische preparaten.
EP0689586B8 (de) Funktion und aktivität des viralen proteins r (vpr)
DE69528170D1 (de) Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen
WO2000029551A3 (en) Cells, culture methods, and their use in autologous transplantation therapy
DE69534633D1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
DE69835828D1 (de) Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression
DK161384C (da) Pyrazolooe3,4,5-klaaacridinforbindelser og farmaceutiske praeparater indeholdende saadanne forbindelser
SE8302580L (sv) Substituerade iminoderivat av dihydrobensopyran och dihydrobensotiopyran och forfarande for deras framstellning
IL83990A0 (en) Cell membrane proteins,compositions containing them and procedure for their preparation
EP0723454A4 (de) Für die immun- und cns-therapir nutzbare, neuartige tripeptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties